On Friday, Acting Secretary of Health and Human Services Eric Hargan renewed the national public health emergency declaration for the opioid epidemic.
WASHINGTON, DC – On Friday, Acting Secretary of Health and Human Services Eric Hargan renewed the national public health emergency declaration for the opioid epidemic. Shatterproof Founder and CEO Gary Mendell released the following statement on the declaration’s reauthorization and President Trump’s progress in the fight against opioids after one year in office.
“The Trump Administration’s national public health declaration has been nothing more than a symbolic gesture. While it has helped draw attention to the opioid crisis, they have fallen short of making any significant progress towards saving lives. As we enter year two of the Trump presidency, the Administration must follow their words with concrete solutions.
“Shatterproof gave the Administration several recommendations, including guaranteeing the right treatment for substance use disorders, enforcing the CDC guideline for prescribing opioids, expanding access to medication-assisted treatment (MAT) and more. The National Governors’ Association (NGA) recommendations released last week are another great place for the President to start. There is no time to waste in the fight against an epidemic that is killing more Americans every day.”
About Gary Mendell:
Gary Mendell is the founder and CEO of Shatterproof. He founded Shatterproof to spare others the tragedy his family suffered with the loss of his son Brian to addiction in 2011. Mr. Mendell is an experienced businessman and CEO who founded HEI Hotels & Resorts and is the former president of Starwood Lodging Trust.
Shatterproof is a national nonprofit organization dedicated to reducing the devastation the disease of addiction causes families. Shatterproof works to end the stigma and foster a community of support, providing evidence-based resources to support prevention, treatment and recovery. Shatterproof advocates for changes in policy at the federal and state level and supports the development and implementation of evidence-based solutions for substance use disorders.